We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Heart Attack Risk Determined by Specific Genes

By LabMedica International staff writers
Posted on 17 Feb 2009
The genetic risk of suffering a heart attack, regardless of a person's ethnic background, might be predicted by a simple blood test. More...


A group of Canadian and British investigators pinpointed specific genes and their association with an increased risk of heart attack. They extracted DNA from 8,795 individuals of European, south Asian, Arab, Iranian, and Nepalese origin and genotyped 1,536 single nucleotide polymorphisms (SNPs) from 103 genes. SNPs are single base pair variations in DNA, which occur within genes and, in some cases, change the production of proteins or alter the expression of other genes.

The results of the study showed a significant association between four genes, and high cholesterol levels, particularly ApolipoproteinB (ApoB)/A1 levels, which is the primary protein involved in "bad cholesterol" and responsible for carrying cholesterol to tissues. The scientists concluded that 13 common SNPs were associated with heart disease risk factors and one variant was independently associated with the risk of a heart attack.

"Most genetic studies have focused on studying white Caucasians," said Professor Sonia Anand, director of the Population Genomics Program at McMaster University (Hamilton, ON, Canada). "The unique contribution of our study is that we demonstrate that common genetic variants are indeed common across five ethnic groups. Furthermore, we are able to put the contribution of these factors on the risk of heart attack into perspective, demonstrating that the nine risk factors account for the vast majority of heart attacks and the genetic variants while important only add a small independent contribution to the risk of heart attack."

An earlier study led by Professor Salim Yusuf at McMaster University showed that nine risk factors accounted for more than 90% of the risk for heart attacks globally. Those nine risk factors are dyslipidemia/high cholesterol, diabetes, hypertension, abdominal obesity, tobacco, physical inactivity, psychosocial stressors, low fruit and vegetable intake, and no alcohol consumption. Together with the genetic variants (SNPs), the prediction of risk of myocardial infarction (MI) was increased by 1.6%.

Scientists believe that common SNPs may be associated with the development of a number of chronic diseases such as cancer, diabetes, vascular disease, and some forms of mental illness.

Related Links:

McMaster University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.